Trial intelligence / Profile preview

IgPro20 (Hizentra) in Primary Immunodeficiency

NCT01199705Phase 3Completed

Sponsor
CSL Limited
Start
Sep 2010
Primary completion
Aug 2011
Modality
Biologic
Countries
1
01

Overview

A Phase 3 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Sep 2010; status: completed.

02

Drugs

IgPro10
03

Conditions

primary immunodeficiency (PI)

Beyond the preview

Go deeper on NCT01199705.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01199705.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call